- Home
- NWN vs MANE Comparison
NWN vs MANE Comparison
Compare NWN & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NWN | MANE |
|---|---|---|
| Founded | 1859 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | NWN | MANE |
|---|---|---|
| Price | $50.75 | $106.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $54.33 | ★ $83.33 |
| AVG Volume (30 Days) | 273.7K | ★ 709.1K |
| Earning Date | 05-06-2026 | 03-30-2026 |
| Dividend Yield | ★ 3.71% | N/A |
| EPS Growth | ★ 36.45 | N/A |
| EPS | ★ 2.33 | N/A |
| Revenue | ★ $1,289,363,000.00 | N/A |
| Revenue This Year | $11.37 | N/A |
| Revenue Next Year | $4.46 | N/A |
| P/E Ratio | $21.87 | ★ N/A |
| Revenue Growth | ★ 11.83 | N/A |
| 52 Week Low | $39.29 | $36.26 |
| 52 Week High | $55.99 | $131.24 |
Technical Indicators
Market Signals| Indicator | NWN | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 54.24 | 46.90 |
| Support Level | $48.36 | $90.90 |
| Resistance Level | $51.93 | $112.83 |
| Average True Range (ATR) | 1.14 | 10.04 |
| MACD | 0.16 | -2.16 |
| Stochastic Oscillator | 50.11 | 8.36 |
Price Performance
Historical ComparisonAbout NWN Northwest Natural Holding Company
Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in three reportable business segments, which are NWN Gas Utility, SiEnergy, and NWN Water. The company generates maximum revenue from NWN Gas Utility segment. It also generates revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.